ResearcherLanzhou University Second HospitalActive in the last 2 years
Yiwei Dai
Matched on ORCID iD 0009-0000-9944-7520; OpenAlex author ID A5102600508. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2024: 2 papers · 2025: 2 papers
Papers 4
- Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer. First author DOI 10.1016/j.jconrel.2025.02.021↗
- A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic cancer therapy efficiency. Co-author DOI 10.1016/j.mtbio.2025.101463↗
- Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer by inhibition of glutamine metabolism. Co-author DOI 10.1016/j.colsurfb.2024.114162↗
- Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment. Co-author DOI 10.1111/cas.16059↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jieru Li · 3 shared papers, 2024–2025 · strength 0.75
- Paper Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer. DOI 10.1016/j.jconrel.2025.02.021↗
- Paper Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer … DOI 10.1016/j.colsurfb.2024.114162↗
- Paper A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic ca… DOI 10.1016/j.mtbio.2025.101463↗
- Yuman Dong · 3 shared papers, 2024–2025 · strength 0.75
- Paper Polyphenol-based pH-responsive nanoparticles enhance chemo-immunotherapy in pancreatic cancer. DOI 10.1016/j.jconrel.2025.02.021↗
- Paper Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer … DOI 10.1016/j.colsurfb.2024.114162↗
- Paper A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic ca… DOI 10.1016/j.mtbio.2025.101463↗
- Zuoyi Jiao · 3 shared papers, 2024–2025 · strength 0.73
- Paper Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment. DOI 10.1111/cas.16059↗
- Paper Self-assembled metal-polyphenolic based multifunctional nanomedicine to improve therapy treatment of pancreatic cancer … DOI 10.1016/j.colsurfb.2024.114162↗
- Paper A novel nanocarrier based on natural polyphenols enhancing gemcitabine sensitization ability for improved pancreatic ca… DOI 10.1016/j.mtbio.2025.101463↗
- Zuoyi Jiao · 1 shared paper, 2025 · strength 0.28
- Zhijian Ma · 1 shared paper, 2024 · strength 0.26
- Xiangyan Jiang · 1 shared paper, 2025 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.